1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Geriatric Medicine Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Analgesics 1.2.3 Antihypertensives 1.2.4 Statins 1.2.5 Antidiabetics 1.2.6 Proton Pump Inhibitor 1.2.7 Anticoagulant 1.2.8 Antipsychotic 1.2.9 Antidepressant 1.3 Market by Application 1.3.1 Global Geriatric Medicine Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Cardiovascular 1.3.3 Arthritis 1.3.4 Neurological 1.3.5 Cancer 1.3.6 Osteoporosis 1.3.7 Respiratory 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Geriatric Medicine Market Perspective (2016-2027) 2.2 Geriatric Medicine Growth Trends by Regions 2.2.1 Geriatric Medicine Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Geriatric Medicine Historic Market Share by Regions (2016-2021) 2.2.3 Geriatric Medicine Forecasted Market Size by Regions (2022-2027) 2.3 Geriatric Medicine Industry Dynamic 2.3.1 Geriatric Medicine Market Trends 2.3.2 Geriatric Medicine Market Drivers 2.3.3 Geriatric Medicine Market Challenges 2.3.4 Geriatric Medicine Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Geriatric Medicine Players by Revenue 3.1.1 Global Top Geriatric Medicine Players by Revenue (2016-2021) 3.1.2 Global Geriatric Medicine Revenue Market Share by Players (2016-2021) 3.2 Global Geriatric Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Geriatric Medicine Revenue 3.4 Global Geriatric Medicine Market Concentration Ratio 3.4.1 Global Geriatric Medicine Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Geriatric Medicine Revenue in 2020 3.5 Geriatric Medicine Key Players Head office and Area Served 3.6 Key Players Geriatric Medicine Product Solution and Service 3.7 Date of Enter into Geriatric Medicine Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Geriatric Medicine Breakdown Data by Type 4.1 Global Geriatric Medicine Historic Market Size by Type (2016-2021) 4.2 Global Geriatric Medicine Forecasted Market Size by Type (2022-2027) 5 Geriatric Medicine Breakdown Data by Application 5.1 Global Geriatric Medicine Historic Market Size by Application (2016-2021) 5.2 Global Geriatric Medicine Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Geriatric Medicine Market Size (2016-2027) 6.2 North America Geriatric Medicine Market Size by Type 6.2.1 North America Geriatric Medicine Market Size by Type (2016-2021) 6.2.2 North America Geriatric Medicine Market Size by Type (2022-2027) 6.2.3 North America Geriatric Medicine Market Size by Type (2016-2027) 6.3 North America Geriatric Medicine Market Size by Application 6.3.1 North America Geriatric Medicine Market Size by Application (2016-2021) 6.3.2 North America Geriatric Medicine Market Size by Application (2022-2027) 6.3.3 North America Geriatric Medicine Market Size by Application (2016-2027) 6.4 North America Geriatric Medicine Market Size by Country 6.4.1 North America Geriatric Medicine Market Size by Country (2016-2021) 6.4.2 North America Geriatric Medicine Market Size by Country (2022-2027) 6.4.3 United States 6.4.3 Canada 7 Europe 7.1 Europe Geriatric Medicine Market Size (2016-2027) 7.2 Europe Geriatric Medicine Market Size by Type 7.2.1 Europe Geriatric Medicine Market Size by Type (2016-2021) 7.2.2 Europe Geriatric Medicine Market Size by Type (2022-2027) 7.2.3 Europe Geriatric Medicine Market Size by Type (2016-2027) 7.3 Europe Geriatric Medicine Market Size by Application 7.3.1 Europe Geriatric Medicine Market Size by Application (2016-2021) 7.3.2 Europe Geriatric Medicine Market Size by Application (2022-2027) 7.3.3 Europe Geriatric Medicine Market Size by Application (2016-2027) 7.4 Europe Geriatric Medicine Market Size by Country 7.4.1 Europe Geriatric Medicine Market Size by Country (2016-2021) 7.4.2 Europe Geriatric Medicine Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Geriatric Medicine Market Size (2016-2027) 8.2 Asia-Pacific Geriatric Medicine Market Size by Type 8.2.1 Asia-Pacific Geriatric Medicine Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Geriatric Medicine Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Geriatric Medicine Market Size by Type (2016-2027) 8.3 Asia-Pacific Geriatric Medicine Market Size by Application 8.3.1 Asia-Pacific Geriatric Medicine Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Geriatric Medicine Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Geriatric Medicine Market Size by Application (2016-2027) 8.4 Asia-Pacific Geriatric Medicine Market Size by Region 8.4.1 Asia-Pacific Geriatric Medicine Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Geriatric Medicine Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Geriatric Medicine Market Size (2016-2027) 9.2 Latin America Geriatric Medicine Market Size by Type 9.2.1 Latin America Geriatric Medicine Market Size by Type (2016-2021) 9.2.2 Latin America Geriatric Medicine Market Size by Type (2022-2027) 9.2.3 Latin America Geriatric Medicine Market Size by Type (2016-2027) 9.3 Latin America Geriatric Medicine Market Size by Application 9.3.1 Latin America Geriatric Medicine Market Size by Application (2016-2021) 9.3.2 Latin America Geriatric Medicine Market Size by Application (2022-2027) 9.3.3 Latin America Geriatric Medicine Market Size by Application (2016-2027) 9.4 Latin America Geriatric Medicine Market Size by Country 9.4.1 Latin America Geriatric Medicine Market Size by Country (2016-2021) 9.4.2 Latin America Geriatric Medicine Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Geriatric Medicine Market Size (2016-2027) 10.2 Middle East & Africa Geriatric Medicine Market Size by Type 10.2.1 Middle East & Africa Geriatric Medicine Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Geriatric Medicine Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Geriatric Medicine Market Size by Type (2016-2027) 10.3 Middle East & Africa Geriatric Medicine Market Size by Application 10.3.1 Middle East & Africa Geriatric Medicine Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Geriatric Medicine Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Geriatric Medicine Market Size by Application (2016-2027) 10.4 Middle East & Africa Geriatric Medicine Market Size by Country 10.4.1 Middle East & Africa Geriatric Medicine Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Geriatric Medicine Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 GSK 11.1.1 GSK Company Details 11.1.2 GSK Business Overview 11.1.3 GSK Geriatric Medicine Introduction 11.1.4 GSK Revenue in Geriatric Medicine Business (2016-2021) 11.1.5 GSK Recent Development 11.2 Boehringer Ingelheim 11.2.1 Boehringer Ingelheim Company Details 11.2.2 Boehringer Ingelheim Business Overview 11.2.3 Boehringer Ingelheim Geriatric Medicine Introduction 11.2.4 Boehringer Ingelheim Revenue in Geriatric Medicine Business (2016-2021) 11.2.5 Boehringer Ingelheim Recent Development 11.3 Novartis 11.3.1 Novartis Company Details 11.3.2 Novartis Business Overview 11.3.3 Novartis Geriatric Medicine Introduction 11.3.4 Novartis Revenue in Geriatric Medicine Business (2016-2021) 11.3.5 Novartis Recent Development 11.4 Bristol-Myers Squibb 11.4.1 Bristol-Myers Squibb Company Details 11.4.2 Bristol-Myers Squibb Business Overview 11.4.3 Bristol-Myers Squibb Geriatric Medicine Introduction 11.4.4 Bristol-Myers Squibb Revenue in Geriatric Medicine Business (2016-2021) 11.4.5 Bristol-Myers Squibb Recent Development 11.5 Pfizer 11.5.1 Pfizer Company Details 11.5.2 Pfizer Business Overview 11.5.3 Pfizer Geriatric Medicine Introduction 11.5.4 Pfizer Revenue in Geriatric Medicine Business (2016-2021) 11.5.5 Pfizer Recent Development 11.6 Eli Lilly 11.6.1 Eli Lilly Company Details 11.6.2 Eli Lilly Business Overview 11.6.3 Eli Lilly Geriatric Medicine Introduction 11.6.4 Eli Lilly Revenue in Geriatric Medicine Business (2016-2021) 11.6.5 Eli Lilly Recent Development 11.7 Abbott 11.7.1 Abbott Company Details 11.7.2 Abbott Business Overview 11.7.3 Abbott Geriatric Medicine Introduction 11.7.4 Abbott Revenue in Geriatric Medicine Business (2016-2021) 11.7.5 Abbott Recent Development 11.8 AstraZeneca 11.8.1 AstraZeneca Company Details 11.8.2 AstraZeneca Business Overview 11.8.3 AstraZeneca Geriatric Medicine Introduction 11.8.4 AstraZeneca Revenue in Geriatric Medicine Business (2016-2021) 11.8.5 AstraZeneca Recent Development 11.9 Merck 11.9.1 Merck Company Details 11.9.2 Merck Business Overview 11.9.3 Merck Geriatric Medicine Introduction 11.9.4 Merck Revenue in Geriatric Medicine Business (2016-2021) 11.9.5 Merck Recent Development 11.10 Sanofi S.A. 11.10.1 Sanofi S.A. Company Details 11.10.2 Sanofi S.A. Business Overview 11.10.3 Sanofi S.A. Geriatric Medicine Introduction 11.10.4 Sanofi S.A. Revenue in Geriatric Medicine Business (2016-2021) 11.10.5 Sanofi S.A. Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Geriatric Medicine Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Analgesics Table 3. Key Players of Antihypertensives Table 4. Key Players of Statins Table 5. Key Players of Antidiabetics Table 6. Key Players of Proton Pump Inhibitor Table 7. Key Players of Anticoagulant Table 8. Key Players of Antipsychotic Table 9. Key Players of Antidepressant Table 10. Global Geriatric Medicine Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 11. Global Geriatric Medicine Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 12. Global Geriatric Medicine Market Size by Regions (2016-2021) & (US$ Million) Table 13. Global Geriatric Medicine Market Share by Regions (2016-2021) Table 14. Global Geriatric Medicine Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 15. Global Geriatric Medicine Market Share by Regions (2022-2027) Table 16. Geriatric Medicine Market Trends Table 17. Geriatric Medicine Market Drivers Table 18. Geriatric Medicine Market Challenges Table 19. Geriatric Medicine Market Restraints Table 20. Global Geriatric Medicine Revenue by Players (2016-2021) & (US$ Million) Table 21. Global Geriatric Medicine Market Share by Players (2016-2021) Table 22. Global Top Geriatric Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Geriatric Medicine as of 2020) Table 23. Ranking of Global Top Geriatric Medicine Companies by Revenue (US$ Million) in 2020 Table 24. Global 5 Largest Players Market Share by Geriatric Medicine Revenue (CR5 and HHI) & (2016-2021) Table 25. Key Players Headquarters and Area Served Table 26. Key Players Geriatric Medicine Product Solution and Service Table 27. Date of Enter into Geriatric Medicine Market Table 28. Mergers & Acquisitions, Expansion Plans Table 29. Global Geriatric Medicine Market Size by Type (2016-2021) (US$ Million) Table 30. Global Geriatric Medicine Revenue Market Share by Type (2016-2021) Table 31. Global Geriatric Medicine Forecasted Market Size by Type (2022-2027) (US$ Million) Table 32. Global Geriatric Medicine Revenue Market Share by Type (2022-2027) & (US$ Million) Table 33. Global Geriatric Medicine Market Size Share by Application (2016-2021) & (US$ Million) Table 34. Global Geriatric Medicine Revenue Market Share by Application (2016-2021) Table 35. Global Geriatric Medicine Forecasted Market Size by Application (2022-2027) (US$ Million) Table 36. Global Geriatric Medicine Revenue Market Share by Application (2022-2027) & (US$ Million) Table 37. North America Geriatric Medicine Market Size by Type (2016-2021) (US$ Million) Table 38. North America Geriatric Medicine Market Size by Type (2022-2027) & (US$ Million) Table 39. North America Geriatric Medicine Market Size by Application (2016-2021) (US$ Million) Table 40. North America Geriatric Medicine Market Size by Application (2022-2027) & (US$ Million) Table 41. North America Geriatric Medicine Market Size by Country (2016-2021) & (US$ Million) Table 42. North America Geriatric Medicine Market Size by Country (2022-2027) & (US$ Million) Table 43. Europe Geriatric Medicine Market Size by Type (2016-2021) (US$ Million) Table 44. Europe Geriatric Medicine Market Size by Type (2022-2027) & (US$ Million) Table 45. Europe Geriatric Medicine Market Size by Application (2016-2021) (US$ Million) Table 46. Europe Geriatric Medicine Market Size by Application (2022-2027) & (US$ Million) Table 47. Europe Geriatric Medicine Market Size by Country (2016-2021) & (US$ Million) Table 48. Europe Geriatric Medicine Market Size by Country (2022-2027) & (US$ Million) Table 49. Asia-Pacific Geriatric Medicine Market Size by Type (2016-2021) (US$ Million) Table 50. Asia-Pacific Geriatric Medicine Market Size by Type (2022-2027) & (US$ Million) Table 51. Asia-Pacific Geriatric Medicine Market Size by Application (2016-2021) (US$ Million) Table 52. Asia-Pacific Geriatric Medicine Market Size by Application (2022-2027) & (US$ Million) Table 53. Asia-Pacific Geriatric Medicine Market Size by Region (2016-2021) & (US$ Million) Table 54. Asia-Pacific Geriatric Medicine Market Size by Region (2022-2027) & (US$ Million) Table 55. Latin America Geriatric Medicine Market Size by Type (2016-2021) (US$ Million) Table 56. Latin America Geriatric Medicine Market Size by Type (2022-2027) & (US$ Million) Table 57. Latin America Geriatric Medicine Market Size by Application (2016-2021) (US$ Million) Table 58. Latin America Geriatric Medicine Market Size by Application (2022-2027) & (US$ Million) Table 59. Latin America Geriatric Medicine Market Size by Country (2016-2021) & (US$ Million) Table 60. Latin America Geriatric Medicine Market Size by Country (2022-2027) & (US$ Million) Table 61. Middle East & Africa Geriatric Medicine Market Size by Type (2016-2021) (US$ Million) Table 62. Middle East & Africa Geriatric Medicine Market Size by Type (2022-2027) & (US$ Million) Table 63. Middle East & Africa Geriatric Medicine Market Size by Application (2016-2021) (US$ Million) Table 64. Middle East & Africa Geriatric Medicine Market Size by Application (2022-2027) & (US$ Million) Table 65. Middle East & Africa Geriatric Medicine Market Size by Country (2016-2021) & (US$ Million) Table 66. Middle East & Africa Geriatric Medicine Market Size by Country (2022-2027) & (US$ Million) Table 67. GSK Company Details Table 68. GSK Business Overview Table 69. GSK Geriatric Medicine Product Table 70. GSK Revenue in Geriatric Medicine Business (2016-2021) & (US$ Million) Table 71. GSK Recent Development Table 72. Boehringer Ingelheim Company Details Table 73. Boehringer Ingelheim Business Overview Table 74. Boehringer Ingelheim Geriatric Medicine Product Table 75. Boehringer Ingelheim Revenue in Geriatric Medicine Business (2016-2021) & (US$ Million) Table 76. Boehringer Ingelheim Recent Development Table 77. Novartis Company Details Table 78. Novartis Business Overview Table 79. Novartis Geriatric Medicine Product Table 80. Novartis Revenue in Geriatric Medicine Business (2016-2021) & (US$ Million) Table 81. Novartis Recent Development Table 82. Bristol-Myers Squibb Company Details Table 83. Bristol-Myers Squibb Business Overview Table 84. Bristol-Myers Squibb Geriatric Medicine Product Table 85. Bristol-Myers Squibb Revenue in Geriatric Medicine Business (2016-2021) & (US$ Million) Table 86. Bristol-Myers Squibb Recent Development Table 87. Pfizer Company Details Table 88. Pfizer Business Overview Table 89. Pfizer Geriatric Medicine Product Table 90. Pfizer Revenue in Geriatric Medicine Business (2016-2021) & (US$ Million) Table 91. Pfizer Recent Development Table 92. Eli Lilly Company Details Table 93. Eli Lilly Business Overview Table 94. Eli Lilly Geriatric Medicine Product Table 95. Eli Lilly Revenue in Geriatric Medicine Business (2016-2021) & (US$ Million) Table 96. Eli Lilly Recent Development Table 97. Abbott Company Details Table 98. Abbott Business Overview Table 99. Abbott Geriatric Medicine Product Table 100. Abbott Revenue in Geriatric Medicine Business (2016-2021) & (US$ Million) Table 101. Abbott Recent Development Table 102. AstraZeneca Company Details Table 103. AstraZeneca Business Overview Table 104. AstraZeneca Revenue in Geriatric Medicine Business (2016-2021) & (US$ Million) Table 105. AstraZeneca Recent Development Table 106. Merck Company Details Table 107. Merck Business Overview Table 108. Merck Geriatric Medicine Product Table 109. Merck Revenue in Geriatric Medicine Business (2016-2021) & (US$ Million) Table 110. Merck Recent Development Table 111. Sanofi S.A. Company Details Table 112. Sanofi S.A. Business Overview Table 113. Sanofi S.A. Geriatric Medicine Product Table 114. Sanofi S.A. Revenue in Geriatric Medicine Business (2016-2021) & (US$ Million) Table 115. Sanofi S.A. Recent Development Table 116. Research Programs/Design for This Report Table 117. Key Data Information from Secondary Sources Table 118. Key Data Information from Primary Sources List of Figures Figure 1. Global Geriatric Medicine Market Share by Type: 2020 VS 2027 Figure 2. Analgesics Features Figure 3. Antihypertensives Features Figure 4. Statins Features Figure 5. Antidiabetics Features Figure 6. Proton Pump Inhibitor Features Figure 7. Anticoagulant Features Figure 8. Antipsychotic Features Figure 9. Antidepressant Features Figure 10. Global Geriatric Medicine Market Share by Application: 2020 VS 2027 Figure 11. Cardiovascular Case Studies Figure 12. Arthritis Case Studies Figure 13. Neurological Case Studies Figure 14. Cancer Case Studies Figure 15. Osteoporosis Case Studies Figure 16. Respiratory Case Studies Figure 17. Geriatric Medicine Report Years Considered Figure 18. Global Geriatric Medicine Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 19. Global Geriatric Medicine Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 20. Global Geriatric Medicine Market Share by Regions: 2020 VS 2027 Figure 21. Global Geriatric Medicine Market Share by Regions (2022-2027) Figure 22. Global Geriatric Medicine Market Share by Players in 2020 Figure 23. Global Top Geriatric Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Geriatric Medicine as of 2020 Figure 24. The Top 10 and 5 Players Market Share by Geriatric Medicine Revenue in 2020 Figure 25. Global Geriatric Medicine Revenue Market Share by Type (2016-2021) Figure 26. Global Geriatric Medicine Revenue Market Share by Type (2022-2027) Figure 27. North America Geriatric Medicine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. North America Geriatric Medicine Market Share by Type (2016-2027) Figure 29. North America Geriatric Medicine Market Share by Application (2016-2027) Figure 30. North America Geriatric Medicine Market Share by Country (2016-2027) Figure 31. United States Geriatric Medicine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Canada Geriatric Medicine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Europe Geriatric Medicine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Europe Geriatric Medicine Market Share by Type (2016-2027) Figure 35. Europe Geriatric Medicine Market Share by Application (2016-2027) Figure 36. Europe Geriatric Medicine Market Share by Country (2016-2027) Figure 37. Germany Geriatric Medicine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. France Geriatric Medicine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. U.K. Geriatric Medicine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Italy Geriatric Medicine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Russia Geriatric Medicine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Nordic Geriatric Medicine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Asia-Pacific Geriatric Medicine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Asia-Pacific Geriatric Medicine Market Share by Type (2016-2027) Figure 45. Asia-Pacific Geriatric Medicine Market Share by Application (2016-2027) Figure 46. Asia-Pacific Geriatric Medicine Market Share by Region (2016-2027) Figure 47. China Geriatric Medicine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Japan Geriatric Medicine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. South Korea Geriatric Medicine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Southeast Asia Geriatric Medicine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. India Geriatric Medicine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Australia Geriatric Medicine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Latin America Geriatric Medicine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Latin America Geriatric Medicine Market Share by Type (2016-2027) Figure 55. Latin America Geriatric Medicine Market Share by Application (2016-2027) Figure 56. Latin America Geriatric Medicine Market Share by Country (2016-2027) Figure 57. Mexico Geriatric Medicine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Brazil Geriatric Medicine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. Middle East & Africa Geriatric Medicine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. Middle East & Africa Geriatric Medicine Market Share by Type (2016-2027) Figure 61. Middle East & Africa Geriatric Medicine Market Share by Application (2016-2027) Figure 62. Middle East & Africa Geriatric Medicine Market Share by Country (2016-2027) Figure 63. Turkey Geriatric Medicine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 64. Saudi Arabia Geriatric Medicine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 65. UAE Geriatric Medicine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 66. GSK Revenue Growth Rate in Geriatric Medicine Business (2016-2021) Figure 67. Boehringer Ingelheim Revenue Growth Rate in Geriatric Medicine Business (2016-2021) Figure 68. Novartis Revenue Growth Rate in Geriatric Medicine Business (2016-2021) Figure 69. Bristol-Myers Squibb Revenue Growth Rate in Geriatric Medicine Business (2016-2021) Figure 70. Pfizer Revenue Growth Rate in Geriatric Medicine Business (2016-2021) Figure 71. Eli Lilly Revenue Growth Rate in Geriatric Medicine Business (2016-2021) Figure 72. Abbott Revenue Growth Rate in Geriatric Medicine Business (2016-2021) Figure 73. AstraZeneca Revenue Growth Rate in Geriatric Medicine Business (2016-2021) Figure 74. Merck Revenue Growth Rate in Geriatric Medicine Business (2016-2021) Figure 75. Sanofi S.A. Revenue Growth Rate in Geriatric Medicine Business (2016-2021) Figure 76. Bottom-up and Top-down Approaches for This Report Figure 77. Data Triangulation Figure 78. Key Executives Interviewed

GSK Boehringer Ingelheim Novartis Bristol-Myers Squibb Pfizer Eli Lilly Abbott AstraZeneca Merck Sanofi S.A.